Carl Walkey

Insider Reports History

Location
Seattle, WA
Signature
/s/ Sean Smith, Attorney-in-Fact for Carl Walkey
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carl Walkey:

Company Role Class Num Shares Value Price $ Report Date Ownership
Neoleukin Therapeutics, Inc. Senior Vice President Stock Option (Right to Buy) 150,000 02 Aug 2022 Direct

Insider Reports Filed by Carl Walkey

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NGNE Neoleukin Therapeutics, Inc. 02 Aug 2022 1 $0 4 Senior Vice President 04 Aug 2022, 16:43
NGNE Neoleukin Therapeutics, Inc. 01 Feb 2022 1 $0 4 Senior Vice President 02 Feb 2022, 15:42
NGNE Neoleukin Therapeutics, Inc. 03 Aug 2021 1 $0 4 Senior Vice President 05 Aug 2021, 16:29
NGNE Neoleukin Therapeutics, Inc. 16 Jun 2021 1 -$6,114 4 Senior Vice President 17 Jun 2021, 21:46
NGNE Neoleukin Therapeutics, Inc. 09 Jun 2021 1 -$7,036 4 Senior Vice President 11 Jun 2021, 16:13
NGNE Neoleukin Therapeutics, Inc. 08 Jun 2021 1 -$6,600 4 Senior Vice President 09 Jun 2021, 17:22
NGNE Neoleukin Therapeutics, Inc. 04 Jun 2021 1 -$6,000 4 Senior Vice President 07 Jun 2021, 17:07
NGNE Neoleukin Therapeutics, Inc. 26 May 2021 1 -$6,000 4 Senior Vice President 26 May 2021, 19:37
NGNE Neoleukin Therapeutics, Inc. 19 May 2021 1 -$6,378 4 Senior Vice President 21 May 2021, 17:24
NGNE Neoleukin Therapeutics, Inc. 12 May 2021 1 -$13,308 4 Senior Vice President 12 May 2021, 20:53